$IBRX
ImmunityBio, Inc. Stock $ibrx

$ibrx Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-Q Financial Statement

#000156459017022217 Filed on November 07, 2017

Income Statement

Concept	2017 Q3	2016 Q3	2016 Q1
Revenue	$8.000K	$12.00K	$6.000K
YoY Change	-33.33%	20.0%	-95.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$13.48M	$24.42M	$26.67M
YoY Change	-44.8%	-41.59%	-15.66%
% of Gross Profit
Research & Development	$10.37M	$8.360M	$4.955M
YoY Change	24.04%	111.65%	725.83%
% of Gross Profit
Depreciation & Amortization	$900.0K	$300.0K	$485.0K
YoY Change	200.0%	-3100.0%	1765.38%
% of Gross Profit
Operating Expenses	$24.45M	$32.79M	$31.62M
YoY Change	-25.43%	-29.44%	-1.86%
Operating Profit	-$24.44M	-$32.78M	-$31.62M
YoY Change	-25.42%	-29.45%	-1.51%
Interest Expense	$393.0K	$29.00K	$0.00
YoY Change	1255.17%		-100.0%
% of Operating Profit
Other Income/Expense, Net	$87.00K	$826.0K	$796.0K
YoY Change	-89.47%	469.66%	-206.56%
Pretax Income	-$24.07M	-$31.95M	-$30.82M
YoY Change	-24.66%	-31.01%	-6.17%
Income Tax	-$100.0K	-$52.00K	-$143.0K
% Of Pretax Income
Net Earnings	-$23.97M	-$31.90M	-$30.68M
YoY Change	-24.86%	-31.13%	-6.61%
Net Earnings / Revenue	-299612.5%	-265808.33%	-511283.33%
Basic Earnings Per Share
Diluted Earnings Per Share	-$301.7K	-$388.3K	-$376.1K
COMMON SHARES
Basic Shares Outstanding			81.93M
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q3	2016 Q3	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$152.3M	$209.3M	$221.8M
YoY Change	-27.23%	-41.63%	344.49%
Cash & Equivalents	$11.20M	$31.40M	$63.25M
Short-Term Investments	$131.3M	$177.9M	$158.5M
Other Short-Term Assets	$286.0K	$252.0K	$190.0K
YoY Change	13.49%	-85.18%	90.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$156.9M	$214.5M	$225.5M
YoY Change	-26.85%	-40.46%	351.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$74.50M	$16.48M	$8.200M
YoY Change	352.2%	1065.13%	4000.0%
Goodwill
YoY Change
Intangibles		$5.948M
YoY Change		-16.97%
Long-Term Investments	$42.70M	$94.70M	$116.2M
YoY Change	-54.91%
Other Assets	$300.0K	$862.0K	$200.0K
YoY Change	-65.2%	-34.99%	-33.33%
Total Long-Term Assets	$120.8M	$117.9M	$131.9M
YoY Change	2.45%	1090.54%	1451.76%
TOTAL ASSETS
Total Short-Term Assets	$156.9M	$214.5M	$225.5M
Total Long-Term Assets	$120.8M	$117.9M	$131.9M
Total Assets	$277.7M	$332.4M	$357.4M
YoY Change	-16.46%	-10.21%	510.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.500M	$2.245M	$1.100M
YoY Change	323.16%	-54.62%	-8.33%
Accrued Expenses	$15.80M	$5.910M	$4.700M
YoY Change	167.34%	424.87%	1466.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$300.0K
YoY Change
Total Short-Term Liabilities	$28.70M	$10.20M	$7.858M
YoY Change	181.37%	52.63%	202.23%
LONG-TERM LIABILITIES
Long-Term Debt	$1.800M	$2.400M	$0.00
YoY Change	-25.0%
Other Long-Term Liabilities	$8.900M	$22.00K	$4.000M
YoY Change	40354.55%	-96.33%	700.0%
Total Long-Term Liabilities	$10.70M	$22.00K	$4.000M
YoY Change	48536.36%	-96.33%	700.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$28.70M	$10.20M	$7.858M
Total Long-Term Liabilities	$10.70M	$22.00K	$4.000M
Total Liabilities	$40.00M	$21.52M	$12.93M
YoY Change	85.87%	196.42%	317.03%
SHAREHOLDERS EQUITY
Retained Earnings		-$358.9M	$31.00M
YoY Change		107.78%
Common Stock		$669.6M	$625.2M
YoY Change		25.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$237.7M	$310.9M	$344.5M
YoY Change
Total Liabilities & Shareholders Equity	$277.7M	$332.4M	$357.4M
YoY Change	-16.46%	-10.21%	510.99%

Cashflow Statement

Concept	2017 Q3	2016 Q3	2016 Q1
OPERATING ACTIVITIES
Net Income	-$23.97M	-$31.90M	-$30.68M
YoY Change	-24.86%	-31.13%	-6.61%
Depreciation, Depletion And Amortization	$900.0K	$300.0K	$485.0K
YoY Change	200.0%	-3100.0%	1765.38%
Cash From Operating Activities	-$10.13M	-$10.68M	-$8.860M
YoY Change	-5.15%	154.29%	20.22%
INVESTING ACTIVITIES
Capital Expenditures	-$10.71M	-$3.080M	$1.067M
YoY Change	247.73%	373.85%	2707.89%
Acquisitions
YoY Change
Other Investing Activities	$17.68M	$9.930M	-$100.9M
YoY Change	78.05%		5441.21%
Cash From Investing Activities	$6.960M	$6.850M	-$101.9M
YoY Change	1.61%	-1153.85%	5379.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$2.550M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-14.95M	-2.990M	-1.890M
YoY Change	400.0%	-101.23%	9350.0%
NET CHANGE
Cash From Operating Activities	-10.13M	-10.68M	-8.860M
Cash From Investing Activities	6.960M	6.850M	-101.9M
Cash From Financing Activities	-14.95M	-2.990M	-1.890M
Net Change In Cash	-18.12M	-6.820M	-112.7M
YoY Change	165.69%	-102.86%	1117.95%
FREE CASH FLOW
Cash From Operating Activities	-$10.13M	-$10.68M	-$8.860M
Capital Expenditures	-$10.71M	-$3.080M	$1.067M
Free Cash Flow	$580.0K	-$7.600M	-$9.927M
YoY Change	-107.63%	114.08%	34.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	82154219
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	293418000
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	317496000
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	996000
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	427000
CY2016Q4	us-gaap	Liabilities Liabilities	24078000
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	8000
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	680757000
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-284000
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-387063000
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-289000
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32186000
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79440700
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81983937
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79440700
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81983937
CY2017Q3	us-gaap	Interest Expense InterestExpense	393000
CY2016Q3	us-gaap	Interest Expense InterestExpense	29000
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	87000
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.39
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	79440591
CY2017Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	59000
CY2016Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-241000
CY2017Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	24000
CY2016Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	48000
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	35000
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23934000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1154000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	28113000
	nk	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	38000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	-709000
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	12456000
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	19868000
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	10000
	nk	Proceeds From Exercise Of Stock Options And Warrants ProceedsFromExerciseOfStockOptionsAndWarrants	1192000
	nk	Proceeds From Exercise Of Stock Options And Warrants ProceedsFromExerciseOfStockOptionsAndWarrants	1044000
	nk	Non Cash Interest Income Expense From Operating Activities NonCashInterestIncomeExpenseFromOperatingActivities	-648000
	nk	Non Cash Interest Income Expense From Operating Activities NonCashInterestIncomeExpenseFromOperatingActivities	273000
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-35140000
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-27840000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	75115000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	207891000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	186815000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	107885000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	79818000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-105208000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	12456000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11898000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	709000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	592000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-31841000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-11456000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	12837000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-144504000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175908000
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31404000
	us-gaap	Interest Paid Net InterestPaidNet	632000
	us-gaap	Interest Paid Net InterestPaidNet	29000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1000
	nk	Noncash Property And Equipment Purchases Acquired Under Capital Lease NoncashPropertyAndEquipmentPurchasesAcquiredUnderCapitalLease	19448000
	nk	Noncash Property And Equipment Purchases Acquired Under Capital Lease NoncashPropertyAndEquipmentPurchasesAcquiredUnderCapitalLease	0
	nk	Estimated Fair Market Value Of Building Under Build To Suit Lease EstimatedFairMarketValueOfBuildingUnderBuildToSuitLease	0
	nk	Estimated Fair Market Value Of Building Under Build To Suit Lease EstimatedFairMarketValueOfBuildingUnderBuildToSuitLease	5139000
	nk	Cashless Exercise Of Stock Options And Warrants CashlessExerciseOfStockOptionsAndWarrants	16000
	nk	Cashless Exercise Of Stock Options And Warrants CashlessExerciseOfStockOptionsAndWarrants	456000
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	179000
CY2017Q3	us-gaap	Prepaid Insurance PrepaidInsurance	816000
CY2016Q4	us-gaap	Prepaid Insurance PrepaidInsurance	531000
CY2017Q3	nk	Equipment And Supply Deposits Current EquipmentAndSupplyDepositsCurrent	602000
CY2016Q4	nk	Equipment And Supply Deposits Current EquipmentAndSupplyDepositsCurrent	482000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	24495770
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25152341
CY2017Q3	nk	Prepaid Services PrepaidServices	1037000
CY2016Q4	nk	Prepaid Services PrepaidServices	1191000
CY2017Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	836000
CY2016Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	1484000
CY2017Q3	nk	Tenant Improvement Allowance Receivable TenantImprovementAllowanceReceivable	387000
CY2016Q4	nk	Tenant Improvement Allowance Receivable TenantImprovementAllowanceReceivable	0
CY2017Q3	nk	Prepaid Legal Fees PrepaidLegalFees	0
CY2016Q4	nk	Prepaid Legal Fees PrepaidLegalFees	350000
CY2017Q3	us-gaap	Other Assets Current OtherAssetsCurrent	286000
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	275000
CY2017Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	77749000
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20084000
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3278000
CY2016Q3	us-gaap	Depreciation Depreciation	300000
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1178000
CY2017Q3	us-gaap	Depreciation Depreciation	900000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3408000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3802000
CY2017Q3	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-359000
CY2016Q3	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-625000
CY2017Q3	nk	Non Cash Build To Suit Lease Asset NonCashBuildToSuitLeaseAsset	5100000
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	418000
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	179000
CY2017Q3	us-gaap	Security Deposit SecurityDeposit	127000
CY2016Q4	us-gaap	Security Deposit SecurityDeposit	137000
CY2017Q3	nk	Equipment Not Placed In Service EquipmentNotPlacedInService	0
CY2016Q4	nk	Equipment Not Placed In Service EquipmentNotPlacedInService	362000
CY2017Q3	nk	Other Sundry Assets Noncurrent OtherSundryAssetsNoncurrent	18000
CY2016Q4	nk	Other Sundry Assets Noncurrent OtherSundryAssetsNoncurrent	110000
CY2017Q3	us-gaap	Construction Payable Current ConstructionPayableCurrent	11068000
CY2016Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	1053000
CY2017Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1434000
CY2016Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1732000
CY2017Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	992000
CY2016Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	898000
CY2017Q3	nk	Accrued Preclinical And Clinical Trial Costs AccruedPreclinicalAndClinicalTrialCosts	651000
CY2016Q4	nk	Accrued Preclinical And Clinical Trial Costs AccruedPreclinicalAndClinicalTrialCosts	662000
CY2017Q3	nk	Accrued Laboratory Equipment And Supplies AccruedLaboratoryEquipmentAndSupplies	393000
CY2016Q4	nk	Accrued Laboratory Equipment And Supplies AccruedLaboratoryEquipmentAndSupplies	190000
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	321000
CY2017Q3	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	501000
CY2016Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	197000
CY2017Q3	nk	Build To Suit Lease Liability Current BuildToSuitLeaseLiabilityCurrent	355000
CY2016Q4	nk	Build To Suit Lease Liability Current BuildToSuitLeaseLiabilityCurrent	281000
CY2017Q3	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	233000
CY2016Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	160000
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1005000
CY2016Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1371000
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-1298000
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-1567000
CY2017Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	34000
CY2016Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	49000
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	30000
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	67000
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
	nk	Available For Sale Securities Maturity Period AvailableForSaleSecuritiesMaturityPeriod	P4Y9M19D
CY2017Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	165720000
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	45000
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	220000
CY2017Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	165545000
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	280698000
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	134000
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	418000
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	280414000
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	110258000
	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses	178000
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	12289000
	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses	42000
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	173920000
CY2016	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses	418000
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0
CY2016	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses	0
CY2017Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	43000
CY2016Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	51000
CY2016Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	800000
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2000000
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	45000
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	143000
CY2017Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	9000
CY2016Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	2000
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	15000
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	76000
CY2017Q3	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	34000
CY2016Q3	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	49000
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	30000
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	67000
CY2017Q3	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	165545000
CY2016Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	280414000
CY2017Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	600000
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2200000
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000
CY2017Q3	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	3072209
CY2016	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	2157944
	nk	Stock Repurchased And Retired During Period Value Before Commissions StockRepurchasedAndRetiredDuringPeriodValueBeforeCommissions	12500000
CY2016	nk	Stock Repurchased And Retired During Period Value Before Commissions StockRepurchasedAndRetiredDuringPeriodValueBeforeCommissions	15800000
	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	100000
CY2017Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	21800000
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8714000
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18669000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	28113000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	62586000
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	31000000
CY2016Q1	nk	Share Based Compensation Arrangement By Share Based Payment Award Accounting Policy Change Additional Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAccountingPolicyChangeAdditionalCompensationCost	27000000
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.00
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-13000
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	39000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	23000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	100000
CY2017Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	15000
CY2016Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-200000
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	43000
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	200000

Files In Submission

Name	View Source	Status
0001564590-17-022217-index-headers.html	Edgar Link	pending
0001564590-17-022217-index.html	Edgar Link	pending
0001564590-17-022217.txt	Edgar Link	pending
0001564590-17-022217-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nk-10q_20170930.htm	Edgar Link	pending
nk-20170930.xml	Edgar Link	completed
nk-20170930.xsd	Edgar Link	pending
nk-20170930_cal.xml	Edgar Link	unprocessable
nk-20170930_def.xml	Edgar Link	unprocessable
nk-20170930_lab.xml	Edgar Link	unprocessable
nk-20170930_pre.xml	Edgar Link	unprocessable
nk-ex311_6.htm	Edgar Link	pending
nk-ex312_7.htm	Edgar Link	pending
nk-ex321_8.htm	Edgar Link	pending
nk-ex322_9.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IBRX
ImmunityBio, Inc. Stock $ibrx

2017 Q3 Form 10-Q Financial Statement

#000156459017022217 Filed on November 07, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IBRX ImmunityBio, Inc. Stock $ibrx

2017 Q3 Form 10-Q Financial Statement

#000156459017022217 Filed on November 07, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IBRX
ImmunityBio, Inc. Stock $ibrx